Insider trading activities (stock purchases, sales, and option exercises) reported by insiders of Neurosense Therapeutics Ltd. (NRSN) since 2026 are shown in Table 1 and Table 2. Table 1 shows the monthly insider trading data of Neurosense Therapeutics Ltd.. Table 2 shows the detailed insider transactions. This company's CIK number is 1875091.
Total stock buying since 2026: $400,000.
Total stock sales since 2026: $0.
Total stock option exercises since 2026: $0.
| Insider Buying | Insider Sales | Option Exercises | ||||
|---|---|---|---|---|---|---|
| Year | Shares | Value | Shares | Value | Shares | Value |
| 2026 | 500,000 | $400,000 | 0 | $0 | 0 | $0 |
| Trading Period | Insider Buying | Insider Sales | Option Exercises | |||
|---|---|---|---|---|---|---|
| year-month | Shares | Value | Shares | Value | Shares | Value |
| 2026-06 | 500,000 | $400,000 | 0 | $0 | 0 | $0 |
| Trade Date | Insider Name | Trade Type | Shares | Price ($) | Value ($) |
|---|---|---|---|---|---|
| 2026-06-16 | Ben-noon Alon (Chief Executive Officer) | Buy | 250,000 | .80 | 200,000 |
| 2026-06-16 | Eisenberg Or (Chief Financial Officer) | Buy | 250,000 | .80 | 200,000 |
Insider trading activities including stock purchases, stock sales, and option exercises of NRSN listed in the above tables cannot be completely guaranteed as to their accuracy. For more insider trading information of Neurosense Therapeutics Ltd. (symbol NRSN, CIK number 1875091) see the Securities and Exchange Commission (SEC) website.